DTL
VRNA

Dynamic Technology Lab’s Verona Pharma VRNA Stock Holding History

Dynamic Technology Lab’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,516
Closed -$204K – 1428
2023
Q3 		$204K Buy
+12,516
New +$241K 0.02% 785
2023
Q2 		– Sell
-12,640
Closed -$253K – 1452
2023
Q1 		$253K Buy
+12,640
New +$273K 0.02% 844

Other funds holding VRNA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Dynamic Technology Lab's VRNA Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Verona Pharma (VRNA) in Q4 2023, closing a stake of 12,516 shares — an estimated $204K sold.

Dynamic Technology Lab first reported a position in VRNA in Q1 2023 and held it in 2 quarters. The position peaked at $253K in Q1 2023. 117 funds tracked by Wall St. Rank hold VRNA as of Q4 2023.

  • Dynamic Technology Lab reported no remaining Verona Pharma position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 12,516 Verona Pharma shares in Q4 2023, an estimated $204K.
  • Dynamic Technology Lab first reported a position in Verona Pharma in Q1 2023 and held it in 2 quarters.
  • Dynamic Technology Lab's Verona Pharma position peaked at $253K in Q1 2023.
  • 117 funds tracked by Wall St. Rank held Verona Pharma as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.